Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 10 posts of 10 posts found.

FDA fast track designation for Biogen’s investigational Alzheimer’s treatment

September 2, 2016
Medical Communications, Research and Development Alzheimer's, Alzheimer’s, Biogen, FDA, aducanumab, fast track

Biogen has announced that its investigational Alzheimer’s disease treatment aducanumab has been granted fast track designation by the FDA. The …

News
Roche image

Roche dealt with two late-stage blows

December 19, 2014
Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …

News
Avanir image

Otsuka buys Avanir for $3.5 billion

December 3, 2014
Sales and Marketing Abilify, Alzheimer's, Alzheimer’s, Nuedexta, Otsuka, Parkinson's, Parkinson’s, avanir

Otsuka is to buy Avanir Pharmaceuticals for $3.5 billion as it looks to make up for the imminent patent expiry …

News
AZ image

AstraZeneca teams up with rival Lilly for Alzheimer’s

September 16, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …

News
nhs image

Alzheimer’s test ‘87% accurate’, say reports

July 9, 2014
Sales and Marketing Alzheimer's, Alzheimer’s, Alzheimer’s & dementia, Cameron, NHS, NHS Choices, dementia

NHS Choices has dampened enthusiasm over a report in medical journal Alzheimer’s & Dementia of a new test for Alzheimer’s …

News
Priddy image

Alzheimer’s disease: pharma’s greatest challenge

April 4, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AD, Alzheimer's, Alzheimer’s, Eisai, Lunt, Pfizer, galantamine, karran, priddy

Like it or not, we are all becoming increasingly prone to a currently incurable and debilitating disease, that places an …

Feature
National Institutes of Health image

Drug giants team up for Alzheimer’s

February 5, 2014
Research and Development, Sales and Marketing Accelerating Medicines Partnership, Alzheimer's, Alzheimer’s, GSK, Merck, National Institutes of Health, Pfizer

The top US medical research agency has brought together a ‘dream team’ of big pharma partners to help battle against …

News
Alzheimer’s image

Alzheimer’s research ‘turning point’

October 11, 2013
Research and Development, Sales and Marketing Alzheimer's, Alzheimer’s, MRC, research

There is new hope that Alzheimer’s disease could be cured, according to a discovery by scientists from the Medical Research …

News
Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

News

Biogen Idec buys neurodegenerative disease rights

December 21, 2010
Research and Development Alzheimer's, Alzheimer's disease, Alzheimer’s, Alzheimer’s disease, Biogen, Biogen IDEC, Neurimmune, Parkinson's disease, Parkinson’s disease, amyotrophic lateral sclerosis, neurodegenerative diseases

Biogen Idec has acquired a subsidiary of Swiss biotech company Neurimmune, and the rights to three pre-clinical immunotherapy drugs. The …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025